Denis Chem Lab Limited

Equities

DENISCHEM6

INE051G01012

Pharmaceuticals

Market Closed - Bombay S.E. 11:00:53 16/05/2024 BST 5-day change 1st Jan Change
185.3 INR -1.59% Intraday chart for Denis Chem Lab Limited -8.83% +46.19%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2021 CI
Denis Chem Lab Limited Announces Standalone Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2021 CI
Denis Chem Lab Limited Announces Standalone Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2020 CI
Denis Chem Lab Limited Announces Resignation of Nahoosh J. Jariwala as Independent Director CI
Denis Chem Lab Limited Reports Unaudited Earnings Results for the Quarter and Nine Months Ended on 31 December, 2019 CI
Denis Chem Lab Limited Announces Resignation of Janak G. Nanavati as Independent Director CI
Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2019 CI
Denis Chem Lab Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2019 CI
Denis Chem Lab Limited Appoints Nahoosh Jayvadan Jariwala as an Independent Director CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018 CI
Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2018 CI
Denis Chem Lab Limited Announces Audited Earnings Results for the Year Ended March 31, 2018 CI
Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the Quarter Ended June 30, 2018 CI
Denis Chem Lab Limited Announces Board Changes CI
Denis Chem Lab Limited Reports Audited Standalone Earnings Results for Fourth Quarter and Full Year Ended March 31, 2018 CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017 CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2017 CI
Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the Quarter Ended June 30, 2017 CI
Denis Chem Lab Limited Announces Audited Earnings Results for the Year Ended March 31, 2017 CI
Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2017 CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2016 CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2016 CI
Denis Chem Lab Limited Reports Unaudited Earnings Results for the First Quarter Ended June 30, 2016 CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2016 CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2015 CI
Chart Denis Chem Lab Limited
More charts
Denis Chem Lab Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing pharmaceutical transfusion solution in bottles. It offers a range of sterile intravenous injectables for human and veterinary consumption. Its product offerings include carbohydrate solutions, carbohydrate in sodium chloride solutions, sodium chloride solutions, potassium chloride solutions, sodium lactate/ Ringer's solution, multi electrolyte solutions, dialysis solutions, mannitol solutions, irrigation solutions, plasma volume expanders, amino acids, antibiotic solutions and other miscellaneous products. It manufactures sterile intravenous injectables in filled volumes ranging from 100 milliliters to 10 liters. In addition to manufacturing its own products, it sells under its own brands. The Company also uses its facility to manufacture products on a contract basis for third parties, including certain multinational pharmaceutical companies.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. DENISCHEM6 Stock
  4. News Denis Chem Lab Limited
  5. Denis Chem Lab : Swings to Loss in Fiscal Q4; Shares Slump 10%